These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 26714660)
41. Determination of the Nail Psoriasis Severity Index improvement rate standards for nail psoriasis treatment in a phase IV clinical trial of ustekinumab: the MARCOPOLO study. Youn SW; Kim BR; Cho S; Seo SJ; Lee ES; Roh JY; Choi GS; Lee MG; J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):e298-e299. PubMed ID: 27976465 [No Abstract] [Full Text] [Related]
42. Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab. Galluzzo M; D'Adamio S; Bianchi L; Talamonti M J Dermatolog Treat; 2019 Feb; 30(1):40-44. PubMed ID: 29676599 [TBL] [Abstract][Full Text] [Related]
43. Therapy response was not altered by HLA-Cw6 status in psoriasis patients treated with secukinumab: a retrospective case series. Anzengruber F; Drach M; Maul JT; Kolios AG; Meier B; Navarini AA J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e274-e276. PubMed ID: 29356172 [No Abstract] [Full Text] [Related]
44. Excellent response to ustekinumab in a 9-year-old girl with severe psoriasis. González-Barreto RM; Rochet NM; Nevares-Pomales OW; Colón-Fontanez F Pediatr Dermatol; 2018 Jan; 35(1):e76-e78. PubMed ID: 29205479 [TBL] [Abstract][Full Text] [Related]
45. Engagement can increase patient willingness to take medications. Johnson MC; Oussedik E; Joshi K; Feldman SR Br J Dermatol; 2019 Aug; 181(2):408-409. PubMed ID: 30738007 [No Abstract] [Full Text] [Related]
46. Inverse psoriasis treated with ustekinumab. Campos MA; Varela P; Baptista A; Moreira AI BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27222277 [TBL] [Abstract][Full Text] [Related]
47. Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in a solid organ transplanted recipient: A case report. Richetta A; Marraffa F; Grassi S; Aquila E; Dybala A; Aprile F; Merli M Australas J Dermatol; 2021 Aug; 62(3):e442-e443. PubMed ID: 33634474 [No Abstract] [Full Text] [Related]
48. Cutaneous mucinosis in a patient taking ustekinumab for palmoplantar psoriasis. Garber C; Rosmarin D; Nguyen B; Goodarzi M; Shinagare S; Jessup C; Madani A; Au SC; Hasanain A Dermatol Online J; 2017 Mar; 23(3):. PubMed ID: 28329515 [TBL] [Abstract][Full Text] [Related]
49. The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis. Rouse NC; Farhangian ME; Wehausen B; Feldman SR Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):877-84. PubMed ID: 26488186 [TBL] [Abstract][Full Text] [Related]
50. Efficiency of Ustekinumab in Crohn's Disease with Severe Psoriasiform Rash Induced by Biotherapies in an Adolescent. Bertrand V; El Haite A; Carré D Pediatr Dermatol; 2017 Jul; 34(4):e214-e215. PubMed ID: 28436109 [TBL] [Abstract][Full Text] [Related]
52. Safety Surveillance for Ustekinumab and Other Psoriasis Treatments From the Psoriasis Longitudinal Assessment and Registry (PSOLAR). Papp K; Gottlieb AB; Naldi L; Pariser D; Ho V; Goyal K; Fakharzadeh S; Chevrier M; Calabro S; Langholff W; Krueger G J Drugs Dermatol; 2015 Jul; 14(7):706-14. PubMed ID: 26151787 [TBL] [Abstract][Full Text] [Related]
53. Successful ustekinumab treatment in a patient with psoriasis and subacute cutaneous lupus erythematosus. Mazgaj M; Picard-Dahan C; Deschamps L; Marinho E; Estève E; Descamps V Int J Dermatol; 2020 Apr; 59(4):e118-e120. PubMed ID: 31957866 [No Abstract] [Full Text] [Related]
54. Inadvertent pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis. Alsenaid A; Prinz JC J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):488-90. PubMed ID: 25413895 [No Abstract] [Full Text] [Related]
55. Exacerbation of systemic lupus erythematosus in a patient with concomitant chronic plaque psoriasis treated with ustekinumab. Goh SW; Jamil A; Nor NM; Cader RA; Shaharir SS Indian J Dermatol Venereol Leprol; 2020; 86(1):68-70. PubMed ID: 31823905 [No Abstract] [Full Text] [Related]
56. Efficacy comparison of ustekinumab between anti-tumor necrosis factor-α drug-naïve and anti-tumor necrosis factor-α drug-resistant Japanese psoriasis cases. Takahashi N; Noda S; Taniguchi T; Adachi M Int J Dermatol; 2015 Oct; 54(10):1194-8. PubMed ID: 26016819 [TBL] [Abstract][Full Text] [Related]
57. Pregnancy outcomes of two patients exposed to ustekinumab in the first trimester. Sheeran C; Nicolopoulos J Australas J Dermatol; 2014 Aug; 55(3):235-6. PubMed ID: 25117169 [No Abstract] [Full Text] [Related]
58. Modulation of inflammatory gene transcripts in psoriasis vulgaris: Differences between ustekinumab and etanercept. Brodmerkel C; Li K; Garcet S; Hayden K; Chiricozzi A; Novitskaya I; Fuentes-Duculan J; Suarez-Farinas M; Campbell K; Krueger JG J Allergy Clin Immunol; 2019 May; 143(5):1965-1969. PubMed ID: 30703387 [No Abstract] [Full Text] [Related]